ArticleInternational journal of molecular sciences2024

A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma Patients.

Domenico Mallardo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.